Announcements in Conjunction With Theratechnologies Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Announcements in Conjunction With Theratechnologies Annual Meeting

MONTREAL, QUEBEC--(Marketwired - May 17, 2016) - Theratechnologies Inc. (TSX:TH) today held its annual meeting of shareholders for the 2015 fiscal year. It was chaired by Dawn Svoronos, chair of the board of Theratechnologies.

As part of the meeting, shareholders proceeded to elect the Company's board of directors for a one-year term and nominated KPMG LLC., as auditors for the current fiscal year. In addition, shareholders adopted a resolution to amend its share option plan (the "Plan") thereby increasing by 1,580,000 the number of common shares reserved for issuance under the Plan and ratified the amendments and renewal of the shareholder rights plan adopted by the directors on April 15, 2016.

All candidates proposed for the position of directors were elected in the following proportion:

IN FAVOUR % IN FAVOUR ABSENTION % ABSTENTION
Gérald A. Lacoste 18,164,765 98.27 320,232 1.73
David Lilley 18,428,079 99.69 56,918 0.31
Paul Pommier 18,237,065 98.66 247,932 1.34
Dawn Svoronos 17,200,730 93.05 1,284,267 6.95
Jean-Denis Talon 18,235,765 98.65 249,232 1.35
Luc Tanguay 18,393,902 99.51 91,095 0.49

In addition to reviewing highlights from last year, both Mrs. Svoronos and Mr. Luc Tanguay, President and CEO of Theratechnologies, shared their vision as to where the Company is heading in the coming years.

"Last year was both a pivotal and a historical year for Theratechnologies. We completed the first full year of commercialisation since regaining the rights to EGRIFTA ® (tesamorelin for injection) in the United States. As a consequence, we recorded our first profitable year ever from our operations. We also ended the year with a positive adjusted EBITDA. We also received approval for EGRIFTA ® in Canada and signed important agreements for Europe and South Korea. I am very pleased to say that we made progress on all fronts which means that the Company is now better positioned than ever to reach new heights," said Luc Tanguay, President and CEO, Theratechnologies Inc.

"The transaction we recently concluded for the commercialisation of ibalizumab in the United States and Canada is definitely a concrete demonstration of how we have given ourselves the tools and leverage we required to grow," added Mr. Tanguay.

"I am particularly enthusiastic about the future of our Company. The strategy to regain commercial rights to EGRIFTA ® in the U.S. was bold but it was what was needed to put us in the position we are in today," said Dawn Svoronos, Chair of the Board, Theratechnologies.

About Theratechnologies

Theratechnologies (TSX:TH) is a specialty pharmaceutical company addressing unmet medical needs to promote healthy ageing and an improved quality of life among HIV patients. Further information about Theratechnologies is available on the Company's website at www.theratech.com and on SEDAR at www.sedar.com .

Forward-Looking Information

This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management's belief and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as "may", "will", "should", "could", "would", "outlook", "believe", "plan", "envisage", "anticipate", "expect" and "estimate", or the negatives of these terms, or variations of them. The forward-looking statements contained in this press release include, but are not limited to, the growth of the Company through sales of EGRIFTA ® and potential sales of ibalizumab if and when approved by regulatory authorities in the United States and Canada.

Forward-looking statements are based upon a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Theratechnologies' control that could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking information. These assumptions include but are not limited to, the following : sales of EGRIFTA ® in the United States and Canada will continue to grow, we will have continuous supply of EGRIFTA ® , the United States Food and Drug Administration and Health Canada will not issue any order or decision having the effect of suspending the commercialization of EGRIFTA ® in the United States and/or Canada, government-sponsored drug plans in Canada will list EGRIFTA ® as a reimbursed drug, results of the Phase III clinical trials with ibalizumab will be positive and ibalizumab will be approved for sale in the United States and in Canada. These risks and uncertainties include, but are not limited to, the risk that sales of EGRIFTA ® decline, that conflicts occur with our third-party service providers, that our intellectual property on tesamorelin is challenged, that unforeseen serious adverse events are reported causing EGRIFTA ® to be withdrawn from the market and that ibalizumab is not filed with regulatory authorities in the United States and Canada or, if filed, is not approved by regulatory authorities because of negative safety or efficacy results or because of third-party suppliers of ibalizumab not meeting regulatory requirements.

We refer potential investors to the "Risk Factors" section of our Annual Information Form dated February 24, 2016 available on SEDAR at www.sedar.com . The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward-looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date.

We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise, except as may be required by applicable law.

Denis Boucher EXOCET Public Relations inc. 514-913-1957
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 152

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 121

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 28

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 83

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 30

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
NeuroPace Faces Investigation After Revenue Forecast Cut

Updated Category News Views 35

NeuroPace Revenue Drama: A Blow to Investor Confidence How the mighty have stumbled—or so it feels to the folks who put their bucks into NeuroPace, Inc. (NASDAQ: NPCE). It's tough to swallow: they cut their 2026 revenue forecast from a hopeful $99.5-$101.5 million to a sobering $91-$92 million. Just one quarter apart those projections are, like a cruel twist of fate...

Continue Reading
Caregiving's Financial Impact on Women: Insights from Cinergy

Updated Category News Views 106

Women Caregivers Face Financial Crossroads When it comes down to it, caregiving is one heck of a responsibility, particularly for women. It's about the sacrifices they make, not just in time but in financial security, too. Step away from a job to care for someone, and it's a dicey game you're playing with future income. The Cost of Generosity: Financial Impacts Cindy...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 22

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 81

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 111

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched for SelectQuote, Inc. Shareholders

Updated Category News Views 231

Rosen Law Firm Investigates SelectQuote, Inc. Securities Claims The Rosen Law Firm has recently announced an investigation focusing on SelectQuote, Inc. (NYSE: SLQT) due to potential securities claims that may affect shareholders. The firm is dedicated to upholding investor rights and protecting shareholders from misleading information that might influence stock...

Continue Reading
Indonesia's IDX Composite Index Experiences Minor Decline

Updated Category News Views 239

Well, let’s cut to the chase. Indonesia's stock market is feeling a bit queasy lately. The IDX Composite Index slipped by 0.18%, taking a hit thanks to major sectors like Financials, Infrastructure, and Agriculture showing significant losses. This isn’t just some random shuffle; these sectors often serve as economic bellwethers that reflect broader trends in the...

Continue Reading
Trade Tensions Impact Qualcomm Stock Performance Today

Updated Category News Views 126

Trade Tensions Impact Qualcomm Shares Qualcomm Inc (NASDAQ: QCOM) is experiencing a decline in its share price, attributed to rising trade tensions. Reports indicate that the U.S. government is preparing to implement restrictions on AI chip shipments to certain Southeast Asian countries, primarily Malaysia and Thailand, due to ongoing concerns regarding China. New Export...

Continue Reading
Historic $100 Million Donation to Improve Pediatric Mental Health

Updated Category News Views 184

Transforming Pediatric Behavioral Health BOSTON — A groundbreaking gift of $100 million from Rob and Karen Hale has been announced by Boston Children's Hospital. This donation marks the largest in the hospital's storied history and is set to revolutionize pediatric behavioral health care. The Hale family's incredible generosity is aimed at reimagining how mental and...

Continue Reading
Mark Carney Takes Charge: Canada's Bold Steps to Trade Victory

Updated Category News Views 414

Mark Carney: Canada's New Prime Minister Mark Carney has emerged victorious in the leadership race of the Liberal Party, succeeding Justin Trudeau as Canada’s prime minister. With a commanding win, he pledged to confront U.S. President Donald Trump head-on, especially regarding increasing trade tensions. A Strong Start in Leadership In a remarkable demonstration of...

Continue Reading